Fairvalue-Calculator Fairvalue-Calculator
EN DE

EBR Systems, Inc (EBRCZ) Fair Value & Analysis

Healthcare · US · Market cap $125M

Price$0.3110
Fair Value$0.1700
Upside-45.3%
Quality91/100
Evidence: Low Range $0.1300 – $0.2100

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

EBR Systems, Inc (EBRCZ) currently trades at $0.3110, while our model-based Fair Value estimate is $0.1700 — implying the stock looks roughly 45.3% overvalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is EBR Systems, Inc (EBRCZ) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.1700 versus a price of $0.3110 — about −45% (overvalued). Model-based estimate, not financial advice.
What is the fair value of EBRCZ?
Our 21-model fair value for EBR Systems, Inc is $0.1700 (as of Jun 24, 2026), built from audited fundamentals. The current price is $0.3110.
What is the quality score of EBRCZ?
EBR Systems, Inc has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.